{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:29:00Z","timestamp":1792697340052,"version":"4.5.0"},"reference-count":17,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Einstein (S\u00e3o Paulo)"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>ABSTRACT Objective To investigate potential intravenous drug incompatibilities and related risk factors in a pediatric unit. Methods A cross-sectional analytical study conducted in the pediatric unit of a university hospital in Brazil. Data on prescriptions given to children aged 0-15 years from June to October 2014 were collected. Prescriptions that did not include intravenous drugs and prescriptions with incomplete dosage regimen or written in poor handwriting were excluded. Associations between variables and the risk of potential incompatibility were investigated using the Student\u2019s t test and ANOVA; the level of significance was set at 5% (p&lt;0.05). Relative risks were calculated for each drug involved in potential incompatibility with 95% confidence interval. Results A total of 222 children participated in the study; 132 (59.5%) children were male and 118 (53.2%) were aged between 0 and 2 years. The mean length of stay was 7.7\u00b12.3 days. Dipyrone, penicillin G and ceftriaxona were the most commonly prescribed drugs. At least one potential incompatibility was detected in about 85% of children (1.2 incompatibility\/patient ratio). Most incompatibilities detected fell into the non-tested (93.4%), precipitation (5.5%), turbidity (0.7%) or chemical decomposition (0.4%) categories. The number of drugs and prescription of diazepam, phenytoin, phenobarbital or metronidazole were risk factors for potential incompatibility. Conclusion Most pediatric prescriptions involved potential incompatibilities, with higher prevalence of non-tested incompatibilities. The number of drugs and prescription of diazepam, phenobarbital, phenytoin or metronidazole were risk factors for potential incompatibilities.<\/jats:p>","DOI":"10.1590\/s1679-45082016ao3723","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T13:18:08Z","timestamp":1469279888000},"page":"185-189","source":"Crossref","is-referenced-by-count":18,"title":["Potential intravenous drug incompatibilities in a pediatric unit"],"prefix":"10.1590","volume":"14","author":[{"given":"Karla Dalliane Batista","family":"Leal","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Weyler Duarte","family":"Leopoldino","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand Randall","family":"Martins","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourena Mafra","family":"Ver\u00edssimo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"19","key":"ref1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2146\/ajhp070633","article-title":"Prevention of intravenous drug incompatibilities in an intensive care unit","volume":"65","author":"Bertsche T","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-0105.134984","article-title":"A clinical study on drug-related problems associated with intravenous drug administration","volume":"5","author":"Vijayakumar A","year":"2014","journal-title":"J Basic Clin Pharm"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1542\/peds.2011-2526","article-title":"Tenfold medication errors: 5 years\u2019 experience at a university-affiliated pediatric hospital","volume":"129","author":"Doherty C","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/qshc.2008.029785","article-title":"Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis","volume":"19","author":"McDowell SE","year":"2010","journal-title":"Qual Saf Health Care"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pedn.2010.04.002","article-title":"Medication administration errors and the pediatric population: a systematic search of the literature","volume":"25","author":"Gonzales K","year":"2010","journal-title":"J Pediatr Nurs"},{"issue":"6","key":"ref6","first-page":"349","article-title":"Incompatibilities in intravenous therapy: what can be done to prevent them?","volume":"19","author":"Secoli SR","year":"2009","journal-title":"Enferm Clin"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2146\/ajhp080059","article-title":"Drug incompatibility chemistry","volume":"66","author":"Newton DW","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/CCM.0b013e3181e8adcc","article-title":"Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units","volume":"38","author":"Kanji S","year":"2010","journal-title":"Crit Care Med"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1023\/A:1008780126781","article-title":"Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit","volume":"22","author":"Gikic M","year":"2000","journal-title":"Pharm World Sci"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmjqs-2013-002357","article-title":"The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study","volume":"23","author":"Nguyen HT","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"ref11","series-title":"WHO Collaborating Centre on Drug Statistics Methodology. ACT\/DDD Index 2016","year":"2015"},{"key":"ref12","series-title":"Micromedex Solutions\u00ae Healthcare Series of Database Vers\u00e3o 2.0","year":"2016"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.5507\/bp.2014.057","article-title":"Incidence of intravenous drug incompatibilities in intensive care units","volume":"159","author":"Machotka O","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref14","series-title":"List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness","first-page":"54082","volume":"63","year":"1998"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s11096-014-0011-1","article-title":"Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients","volume":"36","author":"Fern\u00e1ndez de Palencia Espinosa MA","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/NAN.0b013e3182425b34","article-title":"Development of a compatibility chart for intravenous Y-site drug administration in a pediatric intensive care unit","volume":"35","author":"Manrique-Rodr\u00edguez S","year":"2012","journal-title":"J Infus Nurs"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.accpm.2014.06.003","article-title":"Compatibility of medications during multi-infusion therapy: a controlled in vitro study on a multilumen infusion device","volume":"34","author":"Perez M","year":"2015","journal-title":"Anaesth Crit Care Pain Med"}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/eins\/v14n2\/1679-4508-eins-14-2-0185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T16:58:57Z","timestamp":1568221137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1679-45082016000200011&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1679-45082016000200011"],"URL":"https:\/\/doi.org\/10.1590\/s1679-45082016ao3723","relation":{},"ISSN":["1679-4508"],"issn-type":[{"value":"1679-4508","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}